Table 2.
Correlations between Vav1 expression and clinicopathological characteristics in GC patients
| Variables | Vav1 expression | Chi-square value | P value | |
|---|---|---|---|---|
|
| ||||
| Positive | Negative | |||
| Gender | 0.030 | 0.864 | ||
| Male | 25 | 35 | ||
| Female | 18 | 27 | ||
| Age | 1.289 | 0.256 | ||
| ≤60 | 29 | 35 | ||
| >60 | 14 | 27 | ||
| Size of tumor | 14.655 | <0.001 | ||
| ≤5 | 22 | 53 | ||
| >5 | 21 | 9 | ||
| Location of tumor | 5.327 | 0.149 | ||
| Lower 1/3 | 12 | 28 | ||
| Middle 1/3 | 8 | 12 | ||
| Upper 1/3 | 18 | 20 | ||
| More than 1/3 | 5 | 2 | ||
| Degree of differentiation | 0.107 | 0.744 | ||
| Well/Moderate | 4 | 7 | ||
| Poor | 39 | 55 | ||
| Lauren’s classification | 0.149 | 0.700 | ||
| Intestinal type | 29 | 44 | ||
| Diffuse type | 14 | 18 | ||
| Serosal invasion* | 3.554 | 0.314 | ||
| T1 | 1 | 7 | ||
| T2 | 1 | 3 | ||
| T3 | 4 | 6 | ||
| T4 | 37 | 46 | ||
| Lymph node metastasis* | 15.638 | 0.001 | ||
| N0 | 10 | 29 | ||
| N1 | 7 | 19 | ||
| N2 | 13 | 6 | ||
| N3 | 13 | 8 | ||
*
7th TNM classification.